
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    ### **Step-by-Step Analysis of the Provided Marker List for Large Intestine scRNA-seq Data** #### **1. List the Key Functional Markers and Their Roles** The following genes are associated with critical cellular functions: - **Neuronal/Glial Function & Development**: - **PLP1** (Proteolipid Protein 1): Myelin sheath formation in oligodendrocytes. - **L1CAM** (L1 Cell Adhesion Molecule): Neuronal migration and axon guidance. - **NRXN1/3** (Neurexin 1/3): Synaptic adhesion molecules in neurons. - **SOX10** (SRY-Box Transcription Factor 10): Neural crest and glial cell differentiation. - **TUBB2B** (Tubulin Beta 2B Class IIB): Neuronal microtubule structure. - **ADARB2** (Adenosine Deaminase RNA Specific B2): RNA editing in neurons. - **CHD2** (Cadherin 2): Neuronal adhesion and synaptic plasticity. - **GRIK3** (Glutamate Ionotropic Receptor Kainate Type Subunit 3): Glutamatergic signaling. - **Cell Adhesion & Migration**: - **CDH19/CDH2** (Cadherin 19/2): Neural cell adhesion. - **IGSF11** (Immunoglobulin Superfamily Member 11): Cell-cell adhesion. - **CADM2** (Cell Adhesion Molecule 2): Synaptic organization. - **FLRT1** (Fibronectin Leucine Rich Transmembrane Protein 1): Axon guidance. - **Wnt Signaling & Development**: - **WNT6**: Involved in intestinal development. - **SFRP5** (Secreted Frizzled-Related Protein 5): Wnt antagonist. - **Ion Transport & Metabolism**: - **ATP1A2** (Na+/K+ ATPase Subunit Alpha 2): Ion transport in glial cells. - **KCNMB4** (Calcium-Activated Potassium Channel Subunit Beta 4): Neuronal excitability. #### **2. List the Key Cell Type Markers and Their Roles** These markers strongly suggest a **neuronal or glial lineage**: - **Neural Crest/Glial Markers**: - **SOX10** (Schwann cells, enteric glia). - **PLP1** (Oligodendrocytes, Schwann cells). - **GFRA2** (GDNF receptor, enteric neurons). - **FOXD3** (Neural crest progenitor marker). - **Neuronal Markers**: - **NRXN1/3**, **SYT10** (Synaptotagmin 10, synaptic vesicles). - **L1CAM**, **CHD2** (Neuronal adhesion). - **ADARB2**, **GRIK3** (Neuronal signaling). - **Enteric Nervous System (ENS) Markers**: - **SOX2** (Enteric glial progenitor marker). - **TUBB2B** (Neuronal cytoskeleton). - **S100B** (not listed, but often co-expressed with SOX10 in glia). #### **3. Cross-reference with Known Databases** - **Human Cell Atlas (HCA)**: - **SOX10**, **PLP1**, **GFRA2** are markers of **enteric glia** in the gut. - **NRXN1/3**, **L1CAM**, **CHD2** are found in **enteric neurons**. - **Tabula Sapiens**: - **SOX10+** cells in the intestine are **glial cells**. - **NRXN1/3+** cells are **neurons**. - **Single-cell studies of the ENS**: - **Enteric glia** express **SOX10, PLP1, GFRA2, S100B**. - **Enteric neurons** express **NRXN1/3, L1CAM, CHD2, SYT10**. #### **4. Determine the Most Probable General Cell Type** Given the strong expression of **SOX10, PLP1, GFRA2, NRXN1/3, L1CAM**, the cluster is most likely **neuronal/glial cells of the enteric nervous system (ENS)**. #### **5. Identify the Top 3 Most Probable Sub Cell Types** Ranked from most to least likely: 1. **Enteric Glial Cells (EGCs)** - **Key markers**: SOX10, PLP1, GFRA2, ATP1A2. - **Supporting evidence**: High SOX10 and PLP1 are definitive for glia. 2. **Enteric Neurons (Cholinergic/Nitrergic)** - **Key markers**: NRXN1/3, L1CAM, SYT10, CHD2. - **Supporting evidence**: Synaptic genes suggest neuronal identity, but SOX10 is more glial. 3. **Neural Crest Progenitors** - **Key markers**: FOXD3, SOX2. - **Supporting evidence**: Lower likelihood due to mature glial/neuronal markers. **Final Subtype Decision**: **Enteric Glial Cells (EGCs)** due to dominant SOX10/PLP1 expression. #### **6. Concise Summary of Analysis** - **Key functional markers**: Neuronal/glial adhesion, synaptic signaling, Wnt modulation. - **Key cell type markers**: SOX10 (glial), PLP1 (glial), NRXN1/3 (neuronal). - **Database cross-reference**: Matches ENS glia in HCA/Tabula Sapiens. - **General cell type**: **Enteric Nervous System (ENS) cells**. - **Most likely subtype**: **Enteric Glial Cells (EGCs)**. **FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    ### **Validation Report** #### **1. Marker Consistency Check** - **Proposed Annotation**: **Enteric Glial Cells (EGCs)** - **Key Markers Used**: - **SOX10**, **PLP1**, **GFRA2**, **ATP1A2** (glial markers) - **NRXN1/3**, **L1CAM**, **CHD2**, **SYT10** (neuronal markers) **Assessment**: ‚úÖ **SOX10**, **PLP1**, **GFRA2**, **ATP1A2**, **NRXN1**, **NRXN3**, **L1CAM**, **CHD2**, **SYT10** are all present in the provided marker list. ‚úÖ **SOX10** and **PLP1** are definitive glial markers, strongly supporting **enteric glia**. ‚úÖ **NRXN1/3**, **L1CAM**, **CHD2**, **SYT10** are neuronal but may indicate a minor neuronal subpopulation. #### **2. Mixed Cell Type Consideration** - **Potential Neuronal Contamination**: - The presence of **NRXN1/3**, **L1CAM**, **SYT10** suggests some neuronal signature. - However, **SOX10** and **PLP1** are dominant, making **glial identity** more likely. - **No strong evidence of a separate neuronal cluster**‚Äîlikely a minor subpopulation or co-expression. #### **3. Final Decision** - **Validation Result**: **VALIDATION PASSED** - **Feedback**: - The annotation as **Enteric Glial Cells (EGCs)** is well-supported by **SOX10**, **PLP1**, and **GFRA2**. - The presence of neuronal markers (**NRXN1/3**, **L1CAM**, **SYT10**) does not invalidate the glial identity but suggests possible **minor neuronal contamination or co-expression**. - **Recommendation**: If further refinement is needed, consider subclustering to check for a distinct neuronal population. Otherwise, the annotation is acceptable. **Final Output**: ``` Validation result: VALIDATION PASSED ```
                </div>
            
                    <div class="agent-section formatting">
                        <h2>üìã Summary</h2>
                        <p class="error-message">Error formatting data: Expecting property name enclosed in double quotes: line 1 column 3 (char 2)</p>
                    </div>
                
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">92</div>
                        <div class="scoring-content">
                            The annotation results demonstrate a strong and scientifically accurate identification of **Enteric Glial Cells (EGCs)** as the primary cell type, supported by key markers such as **SOX10**, **PLP1**, and **GFRA2**. These markers are well-documented in the literature and databases (e.g., Human Cell Atlas, Tabula Sapiens) for their roles in glial cell identity and function in the enteric nervous system (ENS). The analysis also appropriately considers the presence of neuronal markers (e.g., **NRXN1/3**, **L1CAM**, **SYT10**) but correctly prioritizes the glial identity due to the dominance of glial-specific markers.<br><br>**Strengths:**<br>1. **Correctness of Annotations**: The final annotation as **EGCs** is highly accurate, given the strong expression of glial markers and the supporting evidence from cross-referenced databases.<br>2. **Balanced Marker Consideration**: The analysis does not over-focus on a single marker but integrates multiple markers (e.g., **SOX10**, **PLP1**, **GFRA2**, **ATP1A2**) to build a robust case for glial identity. It also acknowledges the presence of neuronal markers, suggesting a nuanced understanding of potential co-expression or minor subpopulations.<br>3. **Comprehensive View**: The annotation captures the general picture of the cell population by identifying the most probable subtypes (EGCs, enteric neurons, neural crest progenitors) and ranking them logically. The inclusion of **WNT6** and **SFRP5** for Wnt signaling further enriches the functional context.<br>4. **Validation**: The coupling validator confirms the annotation's validity and provides constructive feedback on potential neuronal contamination, demonstrating a rigorous review process.<br><br>**Weaknesses:**<br>1. **Minor Oversight in Neuronal Contamination**: While the analysis notes the presence of neuronal markers, it could more explicitly address whether these markers suggest a distinct neuronal subpopulation or merely co-expression in glial cells. Subclustering might be necessary to resolve this ambiguity.<br>2. **Rank of Markers**: The analysis does not explicitly discuss the rank or expression levels of the markers (e.g., whether **SOX10** is the most highly expressed). This could strengthen the argument for glial dominance if highlighted.<br>3. **Lack of S100B**: The absence of **S100B**, a classic glial marker, is not discussed. While not critical, its mention could have provided additional support for the glial annotation.<br><br>**Overall**, the annotation is highly accurate and comprehensive, with minor room for refinement in addressing neuronal marker implications and marker ranking. The analysis successfully captures the general picture of the data and provides a scientifically sound conclusion.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    